ARWR
Price
$20.44
Change
+$0.38 (+1.89%)
Updated
Nov 5, 04:52 PM (EDT)
20 days until earnings call
BEAM
Price
$23.89
Change
-$0.47 (-1.93%)
Updated
Nov 5, 04:55 PM (EDT)
Earnings call today
Ad is loading...

ARWR vs BEAM

Header iconARWR vs BEAM Comparison
Open Charts ARWR vs BEAMBanner chart's image
Arrowhead Pharmaceuticals
Price$20.44
Change+$0.38 (+1.89%)
Volume$1.29K
CapitalizationN/A
Beam Therapeutics
Price$23.89
Change-$0.47 (-1.93%)
Volume$21.35K
CapitalizationN/A
View a ticker or compare two or three
ARWR vs BEAM Comparison Chart
Loading...
ARWR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ARWR vs. BEAM commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARWR is a StrongSell and BEAM is a Hold.

COMPARISON
Comparison
Nov 05, 2024
Stock price -- (ARWR: $20.06 vs. BEAM: $24.36)
Brand notoriety: ARWR: Notable vs. BEAM: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARWR: 58% vs. BEAM: 139%
Market capitalization -- ARWR: $2.49B vs. BEAM: $2.01B
ARWR [@Biotechnology] is valued at $2.49B. BEAM’s [@Biotechnology] market capitalization is $2.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $498.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARWR’s FA Score shows that 1 FA rating(s) are green whileBEAM’s FA Score has 0 green FA rating(s).

  • ARWR’s FA Score: 1 green, 4 red.
  • BEAM’s FA Score: 0 green, 5 red.
According to our system of comparison, both ARWR and BEAM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARWR’s TA Score shows that 4 TA indicator(s) are bullish while BEAM’s TA Score has 5 bullish TA indicator(s).

  • ARWR’s TA Score: 4 bullish, 4 bearish.
  • BEAM’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than ARWR.

Price Growth

ARWR (@Biotechnology) experienced а -0.59% price change this week, while BEAM (@Biotechnology) price change was +8.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +14.28%, and the average quarterly price growth was +9.90%.

Reported Earning Dates

ARWR is expected to report earnings on Feb 05, 2025.

BEAM is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARWR($2.49B) has a higher market cap than BEAM($2.01B). BEAM YTD gains are higher at: -10.507 vs. ARWR (-34.444). BEAM has higher annual earnings (EBITDA): -162.88M vs. ARWR (-508.26M). BEAM has more cash in the bank: 1.01B vs. ARWR (434M). ARWR has less debt than BEAM: ARWR (118M) vs BEAM (165M). BEAM has higher revenues than ARWR: BEAM (353M) vs ARWR (19.6M).
ARWRBEAMARWR / BEAM
Capitalization2.49B2.01B124%
EBITDA-508.26M-162.88M312%
Gain YTD-34.444-10.507328%
P/E RatioN/AN/A-
Revenue19.6M353M6%
Total Cash434M1.01B43%
Total Debt118M165M72%
FUNDAMENTALS RATINGS
ARWR: Fundamental Ratings
ARWR
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARWRBEAM
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
83%
Bearish Trend 14 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
ARWR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MLPAX7.980.07
+0.88%
Invesco SteelPath MLP Alpha A
TRASX16.030.03
+0.19%
T. Rowe Price Asia Opportunities I
AASMX23.840.04
+0.17%
Thrivent Small Cap Stock A
MEIHX52.83-0.14
-0.26%
MFS Value R3
ARTLX15.39-0.06
-0.39%
Artisan Value Investor

ARWR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARWR has been loosely correlated with NTLA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ARWR jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARWR
1D Price
Change %
ARWR100%
+2.92%
NTLA - ARWR
51%
Loosely correlated
+2.30%
EDIT - ARWR
49%
Loosely correlated
-1.03%
BEAM - ARWR
48%
Loosely correlated
+6.24%
ALNY - ARWR
46%
Loosely correlated
-1.45%
AXON - ARWR
46%
Loosely correlated
+1.35%
More

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+6.24%
CRSP - BEAM
74%
Closely correlated
-0.28%
NTLA - BEAM
68%
Closely correlated
+2.30%
EDIT - BEAM
65%
Loosely correlated
-1.03%
DNLI - BEAM
65%
Loosely correlated
+0.59%
PRME - BEAM
64%
Loosely correlated
-1.49%
More